Xgeva (Denosumab) 120 Mg Injection


Medical Evidence xgeva

Generic nam e: Denosumab.

Trade name : Xgeva.

Manufacturer information :

Xgeva is manufactured by Amgen Inc.

Xgeva FDA Approval :

Xgeva first approved November 18th, 2010.

Xgeva Indication and Dosage form :



Indication Dosage form
Osteoporosis Treatment of men and postmenopausal women with osteoporosis who are at high risk for fracture; treatment to Prolia: 60 mg SC every 6 monthsSupplement with calcium 1000 mg/day and vitamin D 400 IU/day.
Aromatase Inhibitor Induced Bone Loss Women with breast cancer: 60 mg (Prolia) SC.
Androgen Deprivation Induced Bone Loss Men with prostate cancer: 60 mg (Prolia) SC.
Skeletal-Related Events 120 mg (1.7 mL).
Giant Cell Tumor 120 mg SC.
Hypercalcemia of Malignancy 120 mg SC.




Xgeva (Denosumab) availability in India

  • You could import this medicine against import permit on Patient Name.
  • Please contact ACT Lifesciences Private Limited for further information.